The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota
- PMID: 7573310
- DOI: 10.1016/s0002-9394(14)72666-2
The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota
Abstract
Purpose: To determine the incidence of Graves' ophthalmopathy.
Methods: A population-based cohort of all Olmsted County, Minnesota, residents who had ophthalmopathy associated with autoimmune thyroid disease between Jan. 1, 1976, and Dec. 31, 1990, was identified through the medical diagnostic index of the Mayo Clinic and the Rochester Epidemiology Project.
Results: One hundred twenty incident patients were identified, of whom 103 (85.8%) were women (P = .00001; normal relative deviate test). The overall age-adjusted incidence rate for women was 16.0 cases per 100,000 population per year, whereas the rate for men was 2.9 cases per 100,000 population per year (standardized rate ratio, 5.5; 95% confidence interval, 3.3 to 9.3). The distribution of incidence rates by five-year age groups included peak incidence rates in the age groups 40 to 44 years and 60 to 64 years in women, and 45 to 49 years and 65 to 69 years in men.
Conclusions: Incidence rates for Graves' ophthalmopathy exhibited an apparent bimodal peak for both men and women, although the peaks for men occurred approximately five years after those for women. No explanation for these trends was apparent from the data collected.
Similar articles
-
Chronology of Graves' ophthalmopathy in an incidence cohort.Am J Ophthalmol. 1996 Apr;121(4):426-34. doi: 10.1016/s0002-9394(14)70439-8. Am J Ophthalmol. 1996. PMID: 8604736
-
The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.Trans Am Ophthalmol Soc. 1994;92:477-588. Trans Am Ophthalmol Soc. 1994. PMID: 7886878 Free PMC article.
-
Clinical features of Graves' ophthalmopathy in an incidence cohort.Am J Ophthalmol. 1996 Mar;121(3):284-90. doi: 10.1016/s0002-9394(14)70276-4. Am J Ophthalmol. 1996. PMID: 8597271
-
Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):273-9. doi: 10.1016/j.beem.2011.10.005. Best Pract Res Clin Endocrinol Metab. 2012. PMID: 22632364 Review.
-
Epidemiology and prevention of Graves' ophthalmopathy.Thyroid. 2002 Oct;12(10):855-60. doi: 10.1089/105072502761016476. Thyroid. 2002. PMID: 12487767 Review.
Cited by
-
Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.Ophthalmol Ther. 2021 Dec;10(4):975-987. doi: 10.1007/s40123-021-00385-8. Epub 2021 Sep 3. Ophthalmol Ther. 2021. PMID: 34478126 Free PMC article.
-
Old Bottle, New Wine: Diplopia Sans Proptosis as the Sole Presentation of Thyroid Orbitopathy.Cureus. 2021 Jun 23;13(6):e15850. doi: 10.7759/cureus.15850. eCollection 2021 Jun. Cureus. 2021. PMID: 34322340 Free PMC article.
-
Graves' ophthalmopathy: a review of immunogenetics.Curr Genomics. 2011 Dec;12(8):564-75. doi: 10.2174/138920211798120844. Curr Genomics. 2011. PMID: 22654556 Free PMC article.
-
The Effect of Thyroid Eye Disease on Corneal Biomechanical Properties.Beyoglu Eye J. 2022 Aug 5;7(3):193-198. doi: 10.14744/bej.2022.08941. eCollection 2022. Beyoglu Eye J. 2022. PMID: 36185985 Free PMC article.
-
[Clinical and neuroradiological diagnostics in Graves' orbitopathy].Ophthalmologe. 2011 May;108(5):417-24. doi: 10.1007/s00347-010-2186-8. Ophthalmologe. 2011. PMID: 21538090 German.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials